Valdoxan side effects, by duration, gender and age (a phase IV clinical study of FDA data)
Summary:
Side effects are reported by people who take Valdoxan (agomelatine). Common side effects include asthenia among females and aggression among males.
The phase IV clinical study is created by eHealthMe based on 611 reports from the FDA, and is updated regularly.
What is Valdoxan?
Valdoxan has active ingredients of agomelatine. eHealthMe is studying from 664 Valdoxan users. Check the latest studies of Valdoxan.
611 people who take Valdoxan and have side effects are studied.
What are the common side effects of Valdoxan, by gender? *
What are the common side effects of Valdoxan, by age (0-1 to 60+)? *
What are the common side effects of Valdoxan, by the time people have been on the drug (< 1 month to 10+ years)? *
* Approximation only. Some reports may have incomplete information.
Do you take Valdoxan?
- Personalize this study to your gender and age- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
How the study uses the data?
The study is based on agomelatine (the active ingredients of Valdoxan) and Valdoxan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies are listed below in case you need more information:
Alternative drugs to, pros and cons of Valdoxan:
- Valdoxan (664 reports)
All Valdoxan side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- High Blood Pressure and drugs of ingredients of eszopiclone - 3 seconds ago
- Tumor and Blood Creatine Phosphokinase Increased - 3 seconds ago
- Valproate Sodium and Xeomin drug interactions for men aged 40-49 - 28 seconds ago
- Metoprolol Succinate and Acute Kidney Failure for Men aged 60+ - 44 seconds ago
- Metoprolol Succinate and Renal Failure Acute for Men aged 60+ - 44 seconds ago
- Metoprolol Succinate and Renal Failure for Men aged 60+ - 45 seconds ago
- Metoprolol Succinate and Kidney Failure for Men aged 60+ - 45 seconds ago
- Metoprolol Succinate and Arf for Men aged 60+ - 46 seconds ago
- Could Finacea cause Peripheral Swelling? - 49 seconds ago
- Arthritis and drugs of ingredients of chlorhexidine gluconate - a minute ago